Navigation Links
Anadys Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights

ceutical companies, its effectiveness at managing its financial resources, its ability to enter into transactions around its product candidates, its ability to successfully develop and market products, difficulties or delays in its preclinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its products, regulatory developments and its ability to obtain additional funding to support its operations.  Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2009, Form 10-Q for the quarter ended September 30, 2010 and Form 8-K filed on October 15, 2010.  All forward-looking statements are qualified in their entirety by this cautionary statement.  Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

Condensed Consolidated Financial StatementsAnadys Pharmaceuticals, Inc.Condensed Consolidated Statements of Operations(In thousands except per share amounts)(Unaudited)Three Months Ended
September 30,Nine Months Ended
September 30,2010200920102009Operating expensesResearch and development





15,546General and administrative1,5102,0234,7526,611Total operating expenses (1)3,9986,04614,02522,157Interest income and other, net22183115565Loss from valuation of common stock warrant liability(767)(1,869)(13)(1,429)Total other (expense) income, net(745)(1,686)102(864)Net loss (1)





(23,021)Net loss per share, basic and diluted (1)





(0.71)Shares used in calculating net loss per share, basic and dilut

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Post Your Comments:
(Date:7/23/2014)... DALLAS , July 23, 2014 ... LLC ("Plaintiff") filed suit in the 116 ... Dallas, Texas , against RegenLab USA, ... Current and Prospective Business Relationships through false ... interference; and, Business Disparagement through libel, ...
(Date:7/23/2014)... Use of Risk Evaluation and Mitigation Strategies (REMS) and ... results in $5.4 billion in lost savings annually, according ... economic consulting firm Matrix Global Advisors (MGA). ... Required by the Food and Drug Administration (FDA) for ... to improve drug safety by ensuring that the benefits ...
(Date:7/23/2014)... 23, 2014 PositiveID Corp. (OTCQB: PSID), based ... is an emerging player in the bio-threat detection ... detection and rapid medical testing. The Company,s proprietary ... Autonomous Networked Detector), was developed under contract with ... & Technology directorate, and $30 million of contract ...
Breaking Medicine Technology:New Analysis Finds $5.4 Billion In Annual Lost Savings From Strategies Geared Toward Delaying Generic Drug Entry 2PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by 2
... The U.S. Food and Drug Administration today ... metastatic breast cancer who have received at least ... (Logo: ) (Logo: ... the second leading cause of cancer related death ...
... Millennium Research Group (MRG), the global authority ... latest peripheral vascular research data for multiple geographies, ... Latin America. MRG,s peripheral vascular reports ... artery disease, including stenting, percutaneous transluminal balloon angioplasty, ...
Cached Medicine Technology:FDA Approves New Treatment Option for Late-Stage Breast Cancer 2New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group 2
(Date:7/23/2014)... TX (PRWEB) July 23, 2014 Ticket ... vs. AS Roma tickets in Dallas, TX at the ... eight team tournament held in the United States and Canada ... the world including teams from La Liga, Serie A, English ... year are Manchester United, Manchester City, Olympiacos, Inter Milan, Liverpool, ...
(Date:7/23/2014)... 23, 2014 Recently, has launched ... the company is announcing a promotion of wedding dresses. ... will end at the end of this month. , ... popular styles, like A-line, mermaid, ball-gown, empire, and more. ... and other special-occasion dresses for women, and the company ...
(Date:7/23/2014)... Battle Creek, MI (PRWEB) July 23, 2014 ... treatment program that gets clients off to a great ... they can believe in, has launched a new Internet ... , “Many people are surprised to learn that Internet ... sexual addiction or drug addiction, but that it’s trapping ...
(Date:7/23/2014)... Pallarito HealthDay Reporter TUESDAY, ... for Obamacare, two federal appeals courts arrived at completely different ... millions of Americans who bought health insurance through the federal ... is headed for a showdown before the U.S. Supreme Court. ... Court for the District of Columbia Circuit said that the ...
(Date:7/23/2014)... arriving at the emergency department, the drug ketamine ... rapid, life-saving intubation, despite decades-old studies that suggested ... a systematic review of 10 recent studies of ... drug" are published online in Annals of ... on Intracranial and Cerebral Perfusion Pressure and Health ...
Breaking Medicine News(10 mins):Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 3Health Launched Its New Collection of Wedding Dresses 2Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 2Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 3Health News:Ketamine can be a wonder drug for ER patients and their physicians 2
... (HealthDay News) -- A gene variant associated with asthma ... of researchers working together in a new national collaboration ... was not present in European Americans and may be ... in black Americans. The researchers, analysis of data ...
... August issue of the Journal of the American College ... in head computed tomography (CT) scans. Head CT is the ... the total number of CT examinations. Magnetic resonance imaging ... a vast majority of brain and spinal indications. However, CT ...
... (HealthDay News) -- Several biomechanical differences appear to separate ... could the study identify ways for recreational golfers to ... said the Stanford University School of Medicine team that ... cameras to analyze the full golf swings -- from ...
... Laxenburg, Austria 28 July 2011 -- Future trends ... improvements in both the quality and quantity of education, ... do not explicitly include education in their analysis may ... journal Science (July 29 2011). ...
... FRIDAY, July 29 (HealthDay News) -- A growing number of ... in which they spend three or more nights together each ... own homes, a new study shows. "Instead of following ... to engage in romantic ties on their own terms ...
... will begin a Phase 1 clinical trial on a ... represents the first new class of anti-TB drugs in ... both drug-susceptible and drug-resistant TB. The study is ... awarded from the National Institutes of Health through the ...
Cached Medicine News:Health News:Education -- a key determinant of population growth and human well-being 2Health News:Education -- a key determinant of population growth and human well-being 3Health News:Even Living Together Is Too Much Commitment for Today's Couples 2
... The Cadwell Cascade is a powerful, multi-modality system ... free-run EMG, stimulated EMG, EEG, and train of ... with portability as a priority. The base weighs ... weighs just 13 lbs. A desktop PC-based system ...
... Endeavor is a neuromonitoring system especially ... monitoring. Endeavor amplifier has 16 channels and ... active electrode inputs. Each channel can be ... or a true differential channel. Endeavor amplifiers ...
... Katena Products, Inc. is the ... dedicated exclusively to ophthalmic surgical ... to over 7,000 customers in ... a global network of distributors, ...
... Blood glucose, medication, food, exercise, stress . ... a diabetes patients overall health. Unfortunately, its ... this vital information on a daily basis. ... day-to-day results or submit the information to ...
Medicine Products: